ADAG Stock Discussion

Adagene Inc. Description

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Artificial Intelligence Immunology Immunotherapy Antibodies Health Care Cancer Immunotherapy Virotherapy Antibody Immunotherapies